Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer. (October 2020) - Hagenaars, S.; de Groot, S.; Cohen, D.; Charehbili, A.; Dekker, T.; Kranenbarg, E.Meershoek-Klein; Duijm-de Carpentier, M.; Pijl, H.; Putter, H.; Tollenaar, R.; Kroep, J.; Mesker, W.; et al.